Synergy CHC (SNYR) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
6 Jan, 2026Opening remarks and agenda
Official business of the 2025 annual meeting was conducted according to a set agenda, with participation limited to stockholders of record and their proxies.
Notice of the meeting and voting materials were mailed to stockholders of record on or about April 28, 2025.
A list of stockholders entitled to vote was available for inspection at the headquarters for 10 days prior.
Board and executive committee updates
Five directors were nominated for election to serve until the 2026 annual meeting: Jack Ross, Alfred Baumbusch, Paul Sorrell, Nitin Kaushal, and Scott Woodburn.
No other nominations for the board were received in accordance with company bylaws.
Shareholder proposals
Proposal to ratify RBSM LLP as independent public accountants for the 2025 fiscal year was presented.
Proposal to amend the 2024 Equity Incentive Plan to increase available shares to 2,252,102 was introduced.
Proposal to amend the Articles of Incorporation to authorize issuance of up to one million shares of Preferred Stock was moved.
Latest events from Synergy CHC
- Q3 sales fell on rebranding, but profitability, liquidity, and growth plans remain strong.SNYR
Q3 202411 Jan 2026 - Profitability maintained amid revenue decline; IPO and new launches set stage for 2025 growth.SNYR
Q4 202426 Dec 2025 - Shelf registration for $100M in securities, with $5.69M ATM offering to fund growth and expansion.SNYR
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Stockholders to vote on director elections, auditor, equity plan, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor, equity plan expansion, and preferred stock authorization.SNYR
Proxy Filing2 Dec 2025 - Health and wellness firm targets Nasdaq IPO to fund growth amid strong 2023 results and high debt.SNYR
Registration Filing30 Nov 2025 - Consumer health company targets Nasdaq IPO to fund growth amid high debt and concentrated sales.SNYR
Registration Filing30 Nov 2025 - IPO aims to fund brand growth and expansion amid recent financial improvement and high leverage.SNYR
Registration Filing30 Nov 2025